FATE $0.75 (+10.72%) Quote details

Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Fate Therapeutics Inc

NASDAQ | FATE

0.75

USD

+0.0729 (+10.72%)

AT CLOSE (AS OF Apr 4, 2025)

$86M

MARKET CAP

-

P/E Ratio

-1.64

EPS

$7

52 Week High

$0.66

52 Week Low

LIFE SCIENCES

Sector

FATE Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

FATE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$75M
Total Revenue $13M
Cost Of Revenue $88M
Costof Goods And Services Sold -
Operating Income -$210M
Selling General And Administrative $74M
Research And Development $135M
Operating Expenses $224M
Investment Income Net $17M
Net Interest Income $17M
Interest Income $17M
Interest Expense -
Non Interest Income $13M
Other Non Operating Income $24M
Depreciation -
Depreciation And Amortization $19M
Income Before Tax -$186M
Income Tax Expense $0
Interest And Debt Expense -
Net Income From Continuing Operations -$169M
Comprehensive Income Net Of Tax -$186M
Ebit -$210M
Ebitda -$177M
Net Income -$186M

Revenue & Profitability

Earnings Performance

Actual: $undefined
Estimate: $undefined
Difference: $undefined
Period Qundefined
Q3 24Q4 24Q1 25−0.2−0.3−0.4−0.5−0.6−0.7-$0.02+$0.01+$0.15+$0.02

FATE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $441M
Total Current Assets $292M
Cash And Cash Equivalents At Carrying Value $36M
Cash And Short Term Investments $279M
Inventory -
Current Net Receivables $3.5M
Total Non Current Assets $149M
Property Plant Equipment $64M
Accumulated Depreciation Amortization Ppe $35M
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $28M
Short Term Investments $243M
Other Current Assets $9.3M
Other Non Current Assets $9K
Total Liabilities $122M
Total Current Liabilities $39M
Current Accounts Payable $9.4M
Deferred Revenue $393K
Current Debt -
Short Term Debt $7.4M
Total Non Current Liabilities $78M
Capital Lease Obligations $85M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $85M
Other Current Liabilities $21M
Other Non Current Liabilities $5.1M
Total Shareholder Equity $319M
Treasury Stock -
Retained Earnings -$1.4B
Common Stock $114K
Common Stock Shares Outstanding $114M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$123M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -$2.6M
Change In Operating Assets -$4.1M
Depreciation Depletion And Amortization $19M
Capital Expenditures $730K
Change In Receivables $1.1M
Change In Inventory -
Profit Loss -$186M
Cashflow From Investment $12M
Cashflow From Financing $100M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock $20M
Proceeds From Repurchase Of Equity $95M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$186M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$75M
Total Revenue $13M
Cost Of Revenue $88M
Costof Goods And Services Sold -
Operating Income -$210M
Selling General And Administrative $74M
Research And Development $135M
Operating Expenses $224M
Investment Income Net $17M
Net Interest Income $17M
Interest Income $17M
Interest Expense -
Non Interest Income $13M
Other Non Operating Income $24M
Depreciation -
Depreciation And Amortization $19M
Income Before Tax -$186M
Income Tax Expense $0
Interest And Debt Expense -
Net Income From Continuing Operations -$169M
Comprehensive Income Net Of Tax -$186M
Ebit -$210M
Ebitda -$177M
Net Income -$186M

FATE Profile

Fate Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. The company is headquartered in San Diego, California.

NVDA
-7.36%
$94.31
MULN
-2.52%
$0.0775
DMN
-7.95%
$0.0139
WCT
43.59%
$0.28
TSLA
-10.42%
$239.43
F
0.42%
$9.58
INTC
-11.50%
$19.85
PLTR
-11.47%
$74.01
AAPL
-7.29%
$188.38
AMZN
-4.15%
$171
RSLS
21.15%
$0.46
IBO
107.48%
$0.9627
MGOL
-20.43%
$0.37
AAL
-0.47%
$9.46
BAC
-7.60%
$34.39
LCID
-1.72%
$2.28
LGMK
-5.70%
$0.0149
ALTM
0.00%
$5.84
CXAI
76.00%
$1.42
SOFI
-10.06%
$9.57
GRAB
-12.44%
$3.73
DNN
-4.03%
$1.19
ICCT
34.99%
$5.71
LILM
-36.97%
$0.052
AREB
392.42%
$19.5
HOOD
-9.80%
$34.51
PFE
-5.43%
$22.97
NIO
-7.49%
$3.46
RIG
-20.22%
$2.17
IQ
-13.40%
$1.81
VALE
-6.68%
$9.08
AVGO
-5.01%
$146.29
NKE
3.00%
$57.25
AMD
-8.57%
$85.76
BBD
-4.37%
$2.19
GOOGL
-3.40%
$145.6
T
-6.85%
$26.64
BTE
-19.00%
$1.62
WBD
-11.90%
$8.07
BABA
-9.89%
$116.54
SGMO
5.50%
$0.6565
SMCI
-7.74%
$29.82
LYT
-16.78%
$0.0982
PBR
-6.28%
$13.13
C
-7.80%
$58.13
JBLU
-5.52%
$3.94
PLUG
0.83%
$1.22
ET
-8.86%
$16.16
MU
-12.94%
$64.72
AGNC
-3.85%
$8.98
MSFT
-3.56%
$359.84
SLB
-11.30%
$34.78
SNAP
0.37%
$8.05
ABEV
-4.55%
$2.31
AMCR
-3.66%
$9.22
CX
-7.55%
$5.14
BTG
-9.25%
$2.65
MARA
0.62%
$11.3
FCX
-13.01%
$29.15
OXY
-7.65%
$40.54
CSCO
-4.83%
$54.54
VZ
-5.68%
$43.03
STSS
-7.19%
$0.0258
CCL
-4.51%
$16.5
GOOG
-3.20%
$147.74
WULF
-1.89%
$2.6
CLF
-4.13%
$6.96
META
-5.06%
$504.73
MRVL
-11.16%
$49.43
NKLA
-28.74%
$0.183
LYG
-7.63%
$3.39
KGC
-7.09%
$11.79
WMT
-4.66%
$83.19
TSM
-6.72%
$146.8
RGTI
-7.98%
$7.5
UBER
-7.49%
$64.62
RIVN
-2.78%
$11.21
QBTS
-11.45%
$6.34
APLD
-13.07%
$4.92
VFC
-1.03%
$11.56
ACHR
-10.66%
$6.2
DGLY
-2.78%
$0.035
HPE
-6.51%
$12.79
SOUN
-11.81%
$7.32
STLA
-4.80%
$9.72
WFC
-7.14%
$60.98
XOM
-7.20%
$104.34
UAA
-1.87%
$5.26
ME
-21.26%
$0.6063
SHOP
-6.56%
$76.89
CUTR
-10.19%
$0.0969
PCG
-4.70%
$16.44
KMI
-8.77%
$25.29
HBAN
-6.39%
$12.6
RXRX
-11.85%
$4.24
BON
-6.00%
$0.0595
ERIC
-6.82%
$6.97
HIMS
-7.15%
$25.99
VRN
-11.80%
$5.53
VRT
-11.95%
$59.41
NVDA
-7.36%
$94.31
MULN
-2.52%
$0.0775
DMN
-7.95%
$0.0139
WCT
43.59%
$0.28
TSLA
-10.42%
$239.43
F
0.42%
$9.58
INTC
-11.50%
$19.85
PLTR
-11.47%
$74.01
AAPL
-7.29%
$188.38
AMZN
-4.15%
$171
RSLS
21.15%
$0.46
IBO
107.48%
$0.9627
MGOL
-20.43%
$0.37
AAL
-0.47%
$9.46
BAC
-7.60%
$34.39
LCID
-1.72%
$2.28
LGMK
-5.70%
$0.0149
ALTM
0.00%
$5.84
CXAI
76.00%
$1.42
SOFI
-10.06%
$9.57
GRAB
-12.44%
$3.73
DNN
-4.03%
$1.19
ICCT
34.99%
$5.71
LILM
-36.97%
$0.052
AREB
392.42%
$19.5
HOOD
-9.80%
$34.51
PFE
-5.43%
$22.97
NIO
-7.49%
$3.46
RIG
-20.22%
$2.17
IQ
-13.40%
$1.81
VALE
-6.68%
$9.08
AVGO
-5.01%
$146.29
NKE
3.00%
$57.25
AMD
-8.57%
$85.76
BBD
-4.37%
$2.19
GOOGL
-3.40%
$145.6
T
-6.85%
$26.64
BTE
-19.00%
$1.62
WBD
-11.90%
$8.07
BABA
-9.89%
$116.54
SGMO
5.50%
$0.6565
SMCI
-7.74%
$29.82
LYT
-16.78%
$0.0982
PBR
-6.28%
$13.13
C
-7.80%
$58.13
JBLU
-5.52%
$3.94
PLUG
0.83%
$1.22
ET
-8.86%
$16.16
MU
-12.94%
$64.72
AGNC
-3.85%
$8.98
MSFT
-3.56%
$359.84
SLB
-11.30%
$34.78
SNAP
0.37%
$8.05
ABEV
-4.55%
$2.31
AMCR
-3.66%
$9.22
CX
-7.55%
$5.14
BTG
-9.25%
$2.65
MARA
0.62%
$11.3
FCX
-13.01%
$29.15
OXY
-7.65%
$40.54
CSCO
-4.83%
$54.54
VZ
-5.68%
$43.03
STSS
-7.19%
$0.0258
CCL
-4.51%
$16.5
GOOG
-3.20%
$147.74
WULF
-1.89%
$2.6
CLF
-4.13%
$6.96
META
-5.06%
$504.73
MRVL
-11.16%
$49.43
NKLA
-28.74%
$0.183
LYG
-7.63%
$3.39
KGC
-7.09%
$11.79
WMT
-4.66%
$83.19
TSM
-6.72%
$146.8
RGTI
-7.98%
$7.5
UBER
-7.49%
$64.62
RIVN
-2.78%
$11.21
QBTS
-11.45%
$6.34
APLD
-13.07%
$4.92
VFC
-1.03%
$11.56
ACHR
-10.66%
$6.2
DGLY
-2.78%
$0.035
HPE
-6.51%
$12.79
SOUN
-11.81%
$7.32
STLA
-4.80%
$9.72
WFC
-7.14%
$60.98
XOM
-7.20%
$104.34
UAA
-1.87%
$5.26
ME
-21.26%
$0.6063
SHOP
-6.56%
$76.89
CUTR
-10.19%
$0.0969
PCG
-4.70%
$16.44
KMI
-8.77%
$25.29
HBAN
-6.39%
$12.6
RXRX
-11.85%
$4.24
BON
-6.00%
$0.0595
ERIC
-6.82%
$6.97
HIMS
-7.15%
$25.99
VRN
-11.80%
$5.53
VRT
-11.95%
$59.41
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.